Literature DB >> 10710227

Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking.

L J Bierut1, J P Rice, H J Edenberg, A Goate, T Foroud, C R Cloninger, H Begleiter, P M Conneally, R R Crowe, V Hesselbrock, T K Li, J I Nurnberger, B Porjesz, M A Schuckit, T Reich.   

Abstract

A recent study showed an association between the dopamine D2 receptor gene (DRD2) and smoking. The purpose of this study was to determine if the familial transmission of smoking is linked to variation at the DRD2 locus in a genetically informative sample. Subjects were identified in alcohol treatment centers and their relatives were recruited for study. All subjects were interviewed to assess alcohol dependence, smoking habits, and psychiatric disorders. Two polymorphisms within the DRD2 gene were analyzed, including the TaqIA polymorphism. The sample consisted of 138 nuclear families with at least one offspring with habitual smoking, and analysis was by the transmission disequilibrium test (TDT), which avoids problems due to population stratification. There was no significant difference in the frequency between DRD2 alleles transmitted and not transmitted to habitual smokers. There also was no evidence for unequal transmission of DRD2 alleles for the phenotypes "ever smoker" or comorbid alcohol dependence and habitual smoking. This study does not support linkage of the DRD2 with smoking.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10710227     DOI: 10.1002/(sici)1096-8628(20000214)90:4<299::aid-ajmg7>3.0.co;2-y

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  23 in total

1.  Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation.

Authors:  Gary E Swan; Karen Suchanek Hudmon; Lisa M Jack; Kymberli Hemberger; Dorit Carmelli; Taline V Khroyan; Huijun Z Ring; Hyman Hops; Judy A Andrews; Elizabeth Tildesley; Dale McBride; Neal Benowitz; Chris Webster; Kirk C Wilhelmsen; Heidi S Feiler; Barbara Koenig; Lorraine Caron; Judy Illes; Li S-C Cheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-10       Impact factor: 4.254

Review 2.  Genetics and smoking cessation improving outcomes in smokers at risk.

Authors:  Caryn E Lerman; Robert A Schnoll; Marcus R Munafò
Journal:  Am J Prev Med       Date:  2007-12       Impact factor: 5.043

Review 3.  Genetics and smoking behavior.

Authors:  Robert A Schnoll; Terrance A Johnson; Caryn Lerman
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

Review 4.  Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data.

Authors:  Marcus R Munafò; Nicholas J Timpson; Sean P David; Shah Ebrahim; Debbie A Lawlor
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

5.  CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.

Authors:  Paulo Roberto Xavier Tomaz; Juliana Rocha Santos; Jaqueline Scholz Issa; Tânia Ogawa Abe; Patrícia Viviane Gaya; José Eduardo Krieger; Alexandre Costa Pereira; Paulo Caleb Júnior Lima Santos
Journal:  Eur J Clin Pharmacol       Date:  2015-07-08       Impact factor: 2.953

Review 6.  Neuroimaging, genetics and the treatment of nicotine addiction.

Authors:  Riju Ray; James Loughead; Ze Wang; John Detre; Edward Yang; Ruben Gur; Caryn Lerman
Journal:  Behav Brain Res       Date:  2008-06-05       Impact factor: 3.332

7.  The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls.

Authors:  Jessica Clague; Paul Cinciripini; Janice Blalock; Xifeng Wu; Karen S Hudmon
Journal:  Behav Genet       Date:  2009-10-15       Impact factor: 2.805

8.  Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; David Scheibal; Emily Hahn; Sharon Shiraga; Eleanor Zamora-Paja; Judah Farahi; Sanjaya Saxena; Edythe D London; James T McCracken
Journal:  Arch Gen Psychiatry       Date:  2006-07

Review 9.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

10.  Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.

Authors:  Alicja Sieminska; Krzysztof Buczkowski; Ewa Jassem; Marek Niedoszytko; Ewa Tkacz
Journal:  BMC Med Genet       Date:  2009-09-17       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.